Vasoactive intestinal peptide levels in the hypothalamus and anterior pituitary do not change in association with the pre-ovulatory prolactin surge in the rat

This publication has 20 references indexed in Scilit:

• The immunostaining for the hypothalamic vasoactive intestinal peptide, but not for β-endorphin, dynorphin-A or methionine-enkephalin, is affected by the glucocorticoid milieu in the rat: correlation with the prolactin secretion
  Regulatory Peptides, 1990
• The Peak Phase of the Proestrous Prolactin Surge Is Blocked by Either Posterior Pituitary Lobectomy or Antisera to Vasoactive Intestinal Peptide*
  Endocrinology, 1989
• Lactation Elevates Vasoactive Intestinal Peptide Messenger Ribonucleic Acid in Rat Suprachiasmatic Nucleus*
  Endocrinology, 1989
• Neuroendocrine Significance of Vasoactive Intestinal Polypeptide^a
  Annals of the New York Academy of Sciences, 1988
• Analysis of peptide histidine-isoleucine/ vasoactive intestinal polypeptideimmunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor-and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus
  Neuroscience, 1987
• Vasoactive Intestinal Polypeptide Is Synthesized in Anterior Pituitary Tissue*
  Endocrinology, 1986
• Antisera to Vasoactive Intestinal Polypeptide Inhibit Basal Prolactin Release from Dispersed Anterior Pituitary Cells
  Neuroendocrinology, 1986
• Vasoactive intestinal peptide in rat hypophysial portal blood: effects of electrical stimulation of various brain areas, the oestrous cycle and anaesthetics
  Journal of Endocrinology, 1985
• Vasoactive Intestinal Peptide Is a Physiological Mediator of Prolactin Release in the Rat*
  Endocrinology, 1985
• Administration of Antisera to Vasoactive Intestinal Polypeptide and Peptide Histidine Isoleucine Attenuates Ether-Induced Prolactin Secretion in Rats
  Neuroendocrinology, 1985